Skip to content

Catena Biosciences

YC S21 · Active · Using protein coupling to build new therapies

Competitors

Adjacent

Also from S21

All of S21

About Catena Biosciences

Catena’s technology lets us attach any two proteins together using an enzyme and the native amino acids tyrosine and cysteine within target proteins. It is a true platform technology because it enables the joining of any two soluble proteins together with minimal engineering and without restrictions due to protein size or complexity. Our work has already been used to modify cancer specific antibodies, CRISPR proteins and even cell surfaces. Our ability to produce modular protein therapeutics in a fraction of the time allows for true library creation across the therapeutics spectrum from oncology, vaccines, inflammatory disease and beyond.

YC batch
S21 · Summer 2021
Status, per YC
Active
Category
Other
Team size
7
Location
San Francisco, CA, USA; Berkeley, CA, USA
Checked
36m ago

YC tags: Biotech, Therapeutics

Catena Biosciences in S21: 391 companies, 34% AI

Catena Biosciences: questions

Which YC batch was Catena Biosciences in?

Catena Biosciences was in Y Combinator's Summer 2021 batch (S21).

Is Catena Biosciences still active?

Y Combinator lists Catena Biosciences as active.

Where is Catena Biosciences based?

Catena Biosciences lists San Francisco, CA, USA; Berkeley, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.